Stock fact sheet · data as of

Braskem S.A. (BAK): fair value, margin of safety and Wheel Score

Basic Materials · Chemicals · Brazil · ADR · Speculative / Distressed

Close1.81
GLS fair value20.041 of 9 models
Margin of safety+91%price below fair value
Wheel Score39No optionscapped: no options
Health4/9Piotroski F-score
Moat0.3/10GLS 10-year score
Market cap$721M3.3M shares a day
Implied vol.-no listed options
P/E-EPS -2.97
Dividend yieldnone
Beta0.73moves less than the market
Next earnings12 Nov 2026in 27 days (after the close)

Is BAK undervalued?

Braskem S.A. (BAK) closed at 1.81 on 16 Oct 2026. The GLS average fair value - the simple average of the 1 valuation models that produced a positive number - is 20.04, which puts the price 91% below it. 1 of the 1 models value the shares above the current price. A gap this wide is rare in our universe of ~7,400 US stocks and is exactly what the Value part of the Wheel Score rewards; it is also where the question "why is it this cheap?" matters most.

Only 1 of the nine models produced a value (DCF); the others need a dividend, positive free cash flow or positive book value the company does not have yet, so the average rests on a narrow base.

The nightly engine files BAK under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for BAK

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF20.04+1007%Present value of the projected free cash flows, discounted at the cost of capital
Graham Number--The most a defensive investor pays for the earnings and book value per share; no value tonight
Graham Growth--Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight
Lynch--EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight
GLS Growth--EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight
10 Cap--Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%; no value tonight
Payback Time--Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV--Earnings power value: current EPS capitalised at 9% with no growth; no value tonight
Zombie (liquidation)-170.39-9514%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target1.50-17%Analysts' average 12-month price target. Not in the average

Quality and financial health

Financial health is weak: BAK passes 4 of the nine Piotroski tests. Our screens drop the stock at the health rule; a low score is often the reason a stock looks cheap on the valuation models. The GLS Moat score is low at 0.3 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.

Returns on capital are thin or negative - ROIC -17.6%, ROE 60.0%, ROA -11.8% - with debt at -4.42 times equity and negative free cash flow.

Braskem S.A. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Ethylene Propylene 32%, Benzene Toluene And Xylene 28%, Other 1 18% (fiscal year FY2025).

Institutional ownership scores 1/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score4 / 9ROIC-17.6%
GLS Moat0.3 / 10ROE60.0%
Debt / equity-4.42ROA-11.8%
Free-cash-flow yield-263.6%Payout ratio0%
Institutions1 / 10Insiders · Congress5 · 5 / 10

Wheel Score 39: No options

BAK has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business; the Wheel Score is capped at 39 and shown as "No options" (39 here). The valuation and quality numbers still apply to owning the shares outright.

Volume runs at 3.3M shares a day on a market cap of $721M, with a beta of 0.73 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 15 of 20.

PartPointsFrom
Value25 / 2591% margin of safety
Health9 / 20Piotroski 4/9
Moat0 / 15moat 0.3/10
Premium0 / 20no option data
Stability15 / 203.3M shares/day, $721M cap, beta 0.73

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

The next earnings report is due on 12 Nov 2026 (after the close), 27 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Chemicals

The 12 companies below are the closest to Braskem S.A. by market cap within the Chemicals industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
WLKP
Westlake Chemical Partners LP
20.9256.92+63%72Good$737M
LXU
LSB Industries, Inc.
10.4614.45+28%74Good$753M
TROX
Tronox Holdings plc
3.459.21+63%45Weak$551M
GPRE
Green Plains Inc.
14.2921.71+34%77Good$1.0B
VHI
Valhi, Inc.
14.3334.73+59%39No options$406M
REX
REX American Resources Corporation
41.7797.42+57%78Good$1.4B
HUN
Huntsman Corporation
8.5629.56+71%45Weak$1.5B
OLN
Olin Corporation
15.5535.37+56%45Weak$1.8B
MEOH
Methanex Corporation
63.6150.41-26%57Fair$4.9B
CE
Celanese Corporation
46.44104.18+55%45Weak$5.1B
SSL
Sasol Limited
15.63127.65+88%83Prime$10.0B
NPT
Texxon Holding Limited Ordinary shares
2.031.65-23%16No options$45M

⚖ Compare BAK with 7 of them   All Basic Materials stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about BAK

Is BAK undervalued right now?

By the GLS models, yes: at 1.81 the stock is 91% below the average fair value of 20.04 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.

What is the Wheel Score of BAK and what does it mean?

BAK has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for BAK?

20.04 per share as of 16 Oct 2026 - the simple average of the 1 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Braskem S.A. report earnings next?

The next earnings report is due on 12 Nov 2026 (after the close), 27 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.

Does BAK have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on BAK, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.